Sale!

BEAN1 Gene Spinocerebellar Ataxia Type 31 Autosomal Dominant Genetic Test

Original price was: $700.Current price is: $500.

-29%

The BEAN1 Gene Spinocerebellar Ataxia Type 31 Autosomal Dominant NGS Genetic DNA Test is a specialized diagnostic examination that identifies mutations in the BEAN1 gene responsible for spinocerebellar ataxia type 31, a progressive neurological disorder affecting coordination and movement. Using next-generation sequencing technology, this test provides comprehensive analysis of the BEAN1 gene to detect pathogenic variants associated with autosomal dominant inheritance patterns. The test is crucial for individuals experiencing symptoms like gait disturbances, tremors, speech difficulties, and coordination problems, as well as those with family history of cerebellar ataxia. Results help confirm diagnosis, guide treatment strategies, and inform family planning decisions. The test is available for $500 USD and provides results within 3-4 weeks from blood or DNA samples.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

BEAN1 Gene Spinocerebellar Ataxia Type 31 Autosomal Dominant NGS Genetic DNA Test

Comprehensive Genetic Testing for Inherited Neurological Disorders

The BEAN1 Gene Spinocerebellar Ataxia Type 31 Autosomal Dominant NGS Genetic DNA Test represents a cutting-edge diagnostic approach for identifying genetic mutations responsible for spinocerebellar ataxia type 31 (SCA31). This progressive neurological condition affects the cerebellum and brainstem, leading to significant coordination and movement challenges. Our advanced testing methodology utilizes next-generation sequencing technology to provide comprehensive analysis of the BEAN1 gene, enabling precise detection of pathogenic variants associated with this autosomal dominant inherited disorder.

What This Test Measures and Detects

This specialized genetic test specifically targets the BEAN1 (Brain-Expressed Associated with NEDD4) gene, which plays a crucial role in neurological function. The test identifies:

  • Pathogenic mutations in the BEAN1 gene associated with SCA31
  • Specific nucleotide repeat expansions that characterize the disorder
  • Autosomal dominant inheritance patterns within families
  • Genetic markers for disease progression and severity prediction
  • Carrier status for family planning considerations

Who Should Consider This Genetic Test

This test is particularly recommended for individuals experiencing neurological symptoms or those with family history of cerebellar disorders:

  • Patients presenting with progressive gait disturbances and imbalance
  • Individuals experiencing intention tremors and coordination difficulties
  • Those with slurred speech (dysarthria) and swallowing problems
  • People with family history of spinocerebellar ataxia or similar neurological conditions
  • Individuals seeking genetic counseling for family planning purposes
  • Patients with unexplained cerebellar atrophy on MRI scans

Significant Benefits of Genetic Testing

Undergoing the BEAN1 Gene Spinocerebellar Ataxia Type 31 test provides numerous advantages:

  • Accurate Diagnosis: Confirms or rules out SCA31 with high precision
  • Early Intervention: Enables proactive management of symptoms
  • Family Planning: Provides crucial information for reproductive decisions
  • Treatment Guidance: Helps neurologists develop targeted treatment strategies
  • Genetic Counseling: Supports informed decision-making for affected families
  • Research Contribution: Advances understanding of rare neurological disorders

Understanding Your Test Results

Our comprehensive genetic counseling support helps you interpret your results effectively:

  • Positive Result: Indicates presence of BEAN1 gene mutation associated with SCA31, confirming diagnosis and enabling appropriate medical management
  • Negative Result: Suggests absence of the specific mutation tested, though other genetic or non-genetic causes should be considered
  • Variant of Uncertain Significance: Identifies genetic changes whose clinical significance requires further investigation
  • Carrier Status: Provides information about inheritance risk for future generations

Test Pricing and Availability

Price Type Amount (USD)
Discount Price $500
Regular Price $700

Nationwide Testing Availability

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more cities. Our network of certified genetic counselors and neurologists ensures comprehensive care regardless of your location.

Take the Next Step Toward Genetic Clarity

Don’t let uncertainty about neurological symptoms affect your quality of life. Our BEAN1 Gene Spinocerebellar Ataxia Type 31 Autosomal Dominant NGS Genetic DNA Test provides the answers you need for informed medical decisions and family planning. With results delivered within 3-4 weeks and comprehensive genetic counseling support, you’ll receive the clarity and guidance necessary to navigate your neurological health journey.

Call us today at +1(267) 388-9828 to schedule your genetic testing appointment or to speak with our genetic counseling team. Take control of your neurological health with definitive genetic testing from America’s trusted genetics laboratory.